The Musk-Altman Showdown: A $97.4 Billion Bid

Hamas has postponed its next hostage release, alleging Israel of breaching their ceasefire agreement. Amos Hochstein, former Biden senior advisor and lead broker of the Israel-Lebanon deal, maps out the next incremental steps toward a stable Middle East. In the U.S., a judge has blocked the Trump administration’s proposed cuts to the National Institutes of Health's research funding. Dr. Scott Gottlieb addresses the potential impacts of these funding reductions on clinical studies, and he considers potential cuts to the FDA, as well. Elon Musk is leading an investor group’s $97.4B offer to take over OpenAI; CEO Sam Altman confirmed to CNBC, he is not taking it seriously. Plus, President Trump has paused enforcement of a law banning US companies from bribing foreign officials, claiming it puts American firms at a disadvantage.

Amos Hochstein - 15:49

Dr. Scott Gottlieb - 28:34

In this episode:

Amos Hochstein, @amoshochstein

Dr. Scott Gottlieb, @ScottGottliebMD

Joe Kernen, @JoeSquawk

Becky Quick, @BeckyQuick

Andrew Ross Sorkin, @andrewrsorkin

Cameron Costa, @CameronCostaNY